Skip to ContentSkip to Navigation
founded in 1614  -  top 100 university
About us Practical matters How to find us J.K.E. Veraart

Publications

A call for the systematic assessment of sexual adverse events in ketamine and esketamine trials and clinical practice

Ketamine-assisted psychotherapies for mental disorders: A historical overview and systematic review

Ketamine for depression: Moving from research to clinical practice

Predicting changes in depressive symptomatology following oral esketamine treatment in treatment-resistant depression: A machine-learning approach

The role of cytochrome P450 polymorphisms in the pharmacokinetics of oral esketamine

ATP-binding cassette transporter polymorphisms and the pharmacokinetics of oral esketamine

Auto-Induction in Oral Esketamine Treatment for Treatment-Resistant Depression: An Exploratory Study

Demographic and clinical predictors of response and remission in the treatment of major depressive disorder with ketamine and esketamine: A systematic review

Oral Esketamine as Alternative for Maintenance Electroconvulsive Therapy in Patients with Treatment-Resistant Depression: A Case Series

Oral esketamine for patients with severe treatment-resistant depression: Effectiveness, safety, and tolerability of a six-week open-label treatment program

Press/media

Ketamine bij hardnekkige depressie: van onderzoek naar de spreekkamer

Is At-Home, Extended-Release Ketamine Coming to Market Soon?

Beter door psychedelica

Ketamine tegen je depressie

Spectaculaire resultaten met ketamine als middel tegen depressie

Zeggen alle psychiaters ja tegen psychedelica?

Kamerleden verrast door positieve resultaten hallucinerende middelen als medicijn

UMCG’ers pleiten in de Tweede Kamer voor centrale regie psychedelische therapie voor kwetsbare patiënten

Sustainable Development Goals

SDG 3 - Good Health and Well-beingSDG 16 - Peace, Justice and Strong Institutions

More information about the Sustainable Development Goals.